Loading...
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
Exenatide is the first drug in the incretin mimetic class and is indicated for treatment of type 2 diabetes mellitus. Although structurally similar to the native glucagon-like peptide, this synthetic form has a much longer duration of action. Randomized trials have shown exenatide to be efficacious...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baylor Health Care System
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1484540/ https://ncbi.nlm.nih.gov/pubmed/17252050 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|